Dr. Byron Dan Crowe Iii, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave # Span2, Boston, MA 02215 Phone: 617-667-7000 |
Basak Basdag, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 866-644-8910 |
Himali H Bhatt, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 |
Anna Ohlrich, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-726-8055 |
Laura Mcnamara, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 667-617-7000 |
Dr. Mitchell Izower, BS, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave # Span2, Boston, MA 02215 Phone: 617-754-4677 |
Roberta R Parks, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 294 Washington St, Suite 219, Boston, MA 02108 Phone: 617-426-5500 |
Kirsten M Courtade, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave # Span2, Boston, MA 02215 Phone: 617-667-7000 |
John Barber, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 |
Virginia Brady, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 |
Joseph Gold Hodgkin, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-726-2000 |
Lixia Deng, Hospitalist Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 |
Andrew R Junkin, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-754-4677 |
Jacob E Lazarus, MD, PHD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 Phone: 617-726-2865 |
Noah Austin Minor, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-632-0362 |
Brian Kumar Persaud, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, W-span 2, Boston, MA 02215 Phone: 617-754-4677 |
Dr. Vinay Kadiyala, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-754-4677 Fax: 617-632-0215 |
Wunnie Brima, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 |
Dr. Stephen Wheeler Linderman, MD, PHD Hospitalist Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, Hospital Medicine, West Span 201, Boston, MA 02215 Phone: 617-754-4677 |
Dr. Dharni Patel, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, West Span 201, Boston, MA 02215 Phone: 617-754-4677 |
News Archive
For the first time, researchers have identified a reliable marker (PDGFRβ) to detect carcinoma-associated fibroblasts (cells within the tumor that encourage growth and metastasis) (CAFs) in oral cancer tissues. With this discovery, anti-PDGFRβ treatment could soon be combined with existing tumor treatments to provide a more effective cancer therapy.
As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechnology companies continue to provide help. So far, more than $25 million in medicines, medical supplies and cash have been committed to relief efforts – and that amount is still growing. The total does not include the contributions of PhRMA member company employees and the many companies committed to matching the pledges of their workers.
A new research tool will allow University of Oregon scientists to replicate an extreme range of environmental conditions in their quest to test and understand the human body's response to everyday stresses.
Psyadon Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) to study ecopipam in patients with Lesch-Nyhan Disease (LND). The first center at which the drug will be evaluated is Emory University under the direction of Dr. Hyder A. Jinnah, MD, PhD. The study is designed to evaluate the safety and tolerability of different doses of ecopipam in adults (group 1), adolescents (group 2) and children (group 3) with LND.
› Verified 9 days ago